SafeX Pro:Depression And Alzheimer's Treatments At A Crossroads

2025-05-05 10:23:33source:Surfwincategory:Invest

Researchers are SafeX Prolaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Invest

Recommend

California DMV apologizes for license plate that some say mocks Oct. 7 attack on Israel

LOS ANGELES (AP) — The California Department of Motor Vehicles has apologized for an “unacceptable a

Jennifer Lopez Ditches Her Signature Nude Lip for an Unexpected Color

Let's get loud for Jennifer Lopez's new beauty era.The multihyphenate recently made the bold move to

NFL Week 4 winners, losers: Bengals in bad place with QB Joe Burrow

The first month of the 2023 NFL is nearly through, and the stretch has given an idea of what a lot o